Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
February 2, 2026 144 Filed by "insiders" prior intended sale of restricted stock. View HTML
February 2, 2026 144 Filed by "insiders" prior intended sale of restricted stock. View HTML
January 30, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 21, 2026 SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
January 12, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 1, 2025 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 17, 2025 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 10, 2025 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 10, 2025 10-Q Quarterly report which provides a continuing view of a company's financial position EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 28, 2025 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us